Small Cap Healthcare
Stocks Ranked by
Market Capitalization
| # | Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|---|
| 326 |
CNXU
326
Conexeu Sciences Inc
CNXU
$252M
| $252M | $9.43 | 5.25% |
|
| 327 |
327
Compugen
CGEN
$251M
| $251M | $2.65 | 8.61% |
|
Small Cap Healthcare Stocks at a Glance
Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.
There are 327 small cap Healthcare stocks — companies in the Healthcare sector with a market cap between $250M and $2B — worth a combined $279B.
The largest by market cap are Progyny (PGNY) at $1.99B, Taysha Gene Therapies (TSHA) at $1.99B and Trulieve Cannabis Corp (TRLV) at $1.97B.
Among institutional investors, First Tracks Biotherapeutics (TRAX) drew the most net new fund positions in Q2 2026: 147 funds opened new positions.
- Combined market cap: $279B across 327 stocks.
- Small Cap: market cap between $250M and $2B.
- Largest constituent: Progyny (PGNY), $1.99B market cap.
- Most net new fund positions in Q2 2026: First Tracks Biotherapeutics (TRAX), +147 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.